1564-49-4 Usage
Uses
Used in Oncology:
ETHYL 1-METHYL-5-NITROIMIDAZOLE-2-CARBOXYLATE is used as a radiosensitizing agent in oncology for its ability to sensitize tumor cells to radiation therapy. This enhances the effectiveness of radiation treatments and may improve patient outcomes in cancer management.
Used in Antimicrobial Applications:
In the field of antimicrobials, ETHYL 1-METHYL-5-NITROIMIDAZOLE-2-CARBOXYLATE is used as an agent against certain infections due to its potential antimicrobial properties. This can be beneficial in treating a range of bacterial and other microbial infections.
Used in Antiparasitic Applications:
ETHYL 1-METHYL-5-NITROIMIDAZOLE-2-CARBOXYLATE also has potential applications in antiparasitic treatments, given its demonstrated antiparasitic properties. This makes it a candidate for use in combating various parasitic diseases.
Used in Pharmaceutical Development:
ETHYL 1-METHYL-5-NITROIMIDAZOLE-2-CARBOXYLATE is used as a key compound in pharmaceutical research and development. Its multifaceted potential in medicine, including cancer treatment and infectious disease management, positions it as an important molecule for further exploration and formulation into new drugs and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 1564-49-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,6 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1564-49:
(6*1)+(5*5)+(4*6)+(3*4)+(2*4)+(1*9)=84
84 % 10 = 4
So 1564-49-4 is a valid CAS Registry Number.
1564-49-4Relevant academic research and scientific papers
EHPATITIS B ANTIVIRAL AGENTS
-
Page/Page column 50, (2016/11/28)
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A-Y-Z-L-R1 (I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Synthesis of Novel Imidazole-Containing DNA Minor Groove Binding Oligopeptides Related to the Antiviral Antibiotic Netropsin
Krowicki, Krzysztof,Lown, J. William
, p. 3493 - 3501 (2007/10/02)
Analysis of the structural and stereochemical requirements for the strict DNA base sequence recognition of (AT)4 and (AT)5 respectively for the oligopeptide minor groove binding agents netropsin and distamycin leads to proposals for the rational structure
